Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1989 1
1991 2
1995 1
1999 2
2000 1
2003 2
2004 1
2005 4
2006 2
2007 1
2008 2
2009 5
2010 6
2011 5
2012 4
2014 2
2015 2
2016 8
2017 6
2018 6
2019 10
2020 12
2021 15
2022 15
2023 15
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Zika Virus Infection, Philippines, 2012.
Buerano CC, Pangilinan LS, Dimamay MTA, Mapua CA, Dimamay MPS, Matias RR, Natividad FF, de Guzman Daroy ML, Hasebe F, Morita K, Moi ML. Buerano CC, et al. Among authors: matias rr. Emerg Infect Dis. 2020 Sep;26(9):2300-2301. doi: 10.3201/eid2609.190896. Emerg Infect Dis. 2020. PMID: 32818418 Free PMC article. No abstract available.
Cephalosporin-Resistant Neisseria gonorrhoeae Isolated in Portugal, 2019.
Pinto M, Matias R, Rodrigues JC, Duarte S, Vieira L, Gonçalves I, Gonçalves MJ, Ramos MH, Gomes JP, Borrego MJ. Pinto M, et al. Among authors: matias r. Sex Transm Dis. 2020 Nov;47(11):e54-e56. doi: 10.1097/OLQ.0000000000001218. Sex Transm Dis. 2020. PMID: 32530860
Do Bioactive Food Compound with Avena sativa L., Linum usitatissimum L. and Glycine max L. Supplementation with Moringa oleifera Lam. Have a Role against Nutritional Disorders? An Overview of the In Vitro and In Vivo Evidence.
Ferreira RDS, Mendonça LABM, Santos CD, Hiane PA, Matias R, Franco OL, de Oliveira AKM, do Nascimento VA, Pott A, Carvalho CME, Guimarães RCA. Ferreira RDS, et al. Among authors: matias r. Nutrients. 2021 Jul 2;13(7):2294. doi: 10.3390/nu13072294. Nutrients. 2021. PMID: 34371804 Free PMC article. Review.
127 results